1. United States Stocks

  2. •

    Process industries

  3. •

    Agricultural commodities/Milling
Cresco Labs, Inc.

Cresco Labs, Inc.

0.57
EUR
+0.00
(+0.18%)
-0.25EPS
263.27MMarket Cap
Nov 06Next Earn
Cresco Labs, Inc.
GETTEX:6CQ
(Gettex)

Recent

price

0.57

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2017
2018
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
- -
- -
- -
- -
- -
- -
- -
- -
0.73
1.09
2.26
3.13
2.83
2.38
2.1
1.85
1.8
Revenue per Share
-1.11
-10.38
-5.82
-3.37
1.36
-3.1
- -
-2.45
-0.03
-0.37
-0.49
-1.22
-0.71
-0.54
-0.22
-0.38
-0.28
Basic EPS, GAAP
-6.63
1
0.15
-1.22
2.4
-0.66
- -
0.86
-0.67
-1.03
-0.46
-0.31
-0.23
- -
0.32
0.1
0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-14.13
-21.68
-25.3
-25.55
-21.91
-26.47
- -
-30.57
1.11
1.42
2.12
2.6
2.08
1.49
1.36
0.95
0.96
Book Value per Share
-14.13
-22.87
-26.37
-25.55
-21.91
-26.47
- -
-30.57
0.41
-0.34
-0.77
-0.44
-0.37
-0.21
-0.29
-0.4
-0.5
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
27
- -
59
118
210
262
298
324
345
355
363
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
43
129
476
822
843
771
724
656
651
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
15.26
-26.65
-4.86
10.68
6.76
8.16
15.09
11.73
9.6
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
2
12
37
45
58
69
66
56
56
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
-2
-43
-102
-320
-212
-176
-74
-135
-101
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
58.58
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
-4.43
-33.61
-21.45
-38.9
-25.16
-22.77
-10.28
-20.65
-15.5
Profit Margin (%)
-1
-1
-1
-1
-1
-1
- -
-1
167
9
-3
133
70
78
200
159
108
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
83
330
584
650
662
616
561
566
LT Debt
- -
-1
-1
-1
-1
-1
- -
-1
283
323
575
798
588
428
388
253
263
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
1.43
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-8.95
- -
- -
- -
-4.9
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-28.04
-30.94
-52.02
-30.67
-30.99
-15.18
-33.22
-25.13
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
23
24
26
LT Borrowings
417
418
420
LT Finance Leases
144
145
147
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
360
370
372
Market Capitalization
416
324
301

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
259
247
246
Cash, Cash Equivalents & STI
58
32
33
Accounts Receivable, Net
38
38
40
Inventories
99
108
111
Total Current Liabilities
100
98
138
Payables & Accruals
75
69
70
ST Debt
23
24
26
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-11.82%
-34.95%
Free Cash Flow
- -
3,140.49%
-68.16%
Net Income, GAAP
- -
37.26%
81.91%
Sales/Revenue/Turnover
- -
10.21%
-9.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
184
184
180
176
724
2025
166
164
165
162
656
2026
151
173
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.16
-0.03
-0.01
-0.22
2025
-0.04
-0.05
-0.05
-0.24
-0.38
2026
-0.04
0.05
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Patanjali Foods Limited (NSE:PATANJALI)
Tilray Brands, Inc. (NASDAQ:TLRY)
Archer-Daniels-Midland Company (NYSE:ADM)
Corteva, Inc. (NYSE:CTVA)
Canopy Growth Corporation (NASDAQ:CGC)
Balrampur Chini Mills Ltd (NSE:BALRAMCHIN)
Business
Cresco Labs Inc. Cresco Labs Inc. (CSE:CL), a vertically integrated multistate cannabis operator, cultivates, manufactures, and distributes a portfolio of branded cannabis products including flower, vape pens, live resins, disposable pens, extracts, edibles, and oils under brands such as Cresco, Sunnyside, FloraCal, Mindy's Edibles, and Kiva; it operates Sunnyside dispensaries focused on consumer education and wholesale distribution nationwide. Founded in 2013 and headquartered in Chicago, Illinois, the company conducts operations across eight U.S. states with 13 production facilities and 71 dispensaries, targeting medical and recreational consumers through premium, consistent cannabis experiences. Recent developments include plans to divest California operations as part of a strategic restructuring in 2025, refinancing of its senior secured credit facility to reduce debt, expansion into Ohio and Florida with new Sunnyside dispensaries, entry into the German medical cannabis market via a manufacturing partnership with Blossom in Portugal, and progress on cultivation build-outs in Kentucky and Pennsylvania for branded product launches in early 2026.

Company News

Company News APIChatGPT

  • businesswire.com

    Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 2026

  • businesswire.com

    Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting

  • marijuanastocks.com

    3 Cannabis Stocks to Watch Heading Out of September

  • businesswire.com

    Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting

  • gurufocus.com

    Cresco Labs Appoints Edward Tilly to Board of Directors

  • businesswire.com

    Cresco Labs Appoints Edward Tilly to Board of Directors

  • zacks.com

    Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?

  • businesswire.com

    Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership

  • marijuanastocks.com

    3 Marijuana Stocks For Investors To Consider

  • seekingalpha.com

    Cresco Labs Inc. (CRLBF) Q2 2026 Earnings Call Transcript

  • zacks.com

    Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates

  • businesswire.com

    Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA

  • businesswire.com

    Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026

  • marijuanastocks.com

    Looking for Cannabis Growth? Watch These 3 Marijuana Stocks in July 2026

  • marijuanastocks.com

    Top Cannabis Companies Building Momentum in June 2026

  • zacks.com

    Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?

  • businesswire.com

    Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank

  • businesswire.com

    Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration

  • zacks.com

    Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why

  • businesswire.com

    Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety